AWS
PLRX icon

Atria Wealth Solutions’s Pliant Therapeutics PLRX Stock Holding History

Atria Wealth Solutions’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,574
Closed -$29.1K – 1793
2025
Q1 		$29.1K Hold
21,574
– – ﹤0.01% 1836
2024
Q4 		$284K Hold
21,574
– – ﹤0.01% 1585
2024
Q3 		$242K Buy
21,574
+9,859
+84% +$123K ﹤0.01% 1653
2024
Q2 		$126K Buy
+11,715
New +$151K ﹤0.01% 1835

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Atria Wealth Solutions's PLRX Position: Q2 2025 in Review

Atria Wealth Solutions sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 21,574 shares — an estimated $29.1K sold.

Atria Wealth Solutions first reported a position in PLRX in Q2 2024 and held it in 4 quarters. The position peaked at $284K in Q4 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Atria Wealth Solutions reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 21,574 Pliant Therapeutics shares in Q2 2025, an estimated $29.1K.
  • Atria Wealth Solutions first reported a position in Pliant Therapeutics in Q2 2024 and held it in 4 quarters.
  • Atria Wealth Solutions's Pliant Therapeutics position peaked at $284K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.